EUROPEAN MARKETS FOR SOFT TISSUE REINFORCEMENT AND REGENERATION is a new market research publication announced by Reportstack. The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a whole. Due to the strictly evidence-based approach throughout Europe, the benefits of biologic products, such as expedited healing and reduced likelihoods of graft rejection, are not seen to outweigh their high costs.
Covidien Ethicon C.R. Bard Integra LifeSciences LifeCell Aesculap/B.Braun Systagenix Medskin Solutions Cook Medical American Medical Systems Boston Scientific Depuy Synthes Tutogen Lowmann & Rauscher Smith & Nephew Coloplast PFM Medical Tornier Botiss Geistlich Baxter/Synovis Stryker Serag-Wiessner Novus Scientific
To access full report with TOC, please visit EUROPEAN MARKETS FOR SOFT TISSUE REINFORCEMENT AND REGENERATION.
Reportstack is one of the leading distributors of market research reports in the world today. We host more than 200,000 research products from the world's top publication houses. These publications are distributed amongst 12 top industry verticals and 62 sub verticals, which are then further classified into 257 business categories and 5000 micro markets. The vast selection criterion provides granular data from the length and breadth of all these industries delivering Reportstack members with cutting edge research products to facilitate strategic business decisions.
Manager - Marketing
Reportstack Market Research